Amundi Global Bioenergy UCITS ETF EUR Acc

What this fund is

Amundi Global Bioenergy UCITS ETF EUR Acc is an exchange-traded fund (ETF) from Amundi, traded under the ticker CWEE (ISIN LU1681046006). In a single purchase you get a diversified basket of holdings rather than a stake in just one business. In plain terms it is about owning small slices of companies, so you share in their growth when they do well — and their falls when they don't, spread broadly across markets worldwide. It passively tracks the Bloomberg BioEnergy Screened Index index — mirroring that market instead of paying a manager to pick winners, which keeps costs low, and its largest holdings include NOVONESIS (NOVOZYMES) B, VALERO ENERGY CORPORATION and VEOLIA ENVIRONNEMENT. Spread across roughly 26 holdings (the ten largest ≈ 75.2%), no one position makes or breaks the fund.

Its biggest country exposures are ~43.4% United States, ~14.9% Finland and ~12.2% France. Its heaviest sectors are ~43.2% Energy and ~18% Materials. Investors often use a broad fund like this as a long-term 'core' holding — a single building block that covers much of a global portfolio in one trade. Its ongoing charge (TER) is 0.35% a year — about €35 a year on a €10,000 holding, taken automatically from the fund. Income such as dividends is automatically reinvested inside the fund (an accumulating share class), so returns compound without you doing anything.

It holds the underlying investments directly (physical replication); it is domiciled in Luxembourg and UCITS-regulated, a European standard built to protect everyday investors and trades in EUR. Its price has swung about 17.6% over the past year, which describes how much its price tends to move rather than whether it is good. It launched in 2018. Like any investment, it can lose value as well as gain, and what it did before does not predict what it will do next. (Fund data sourced from Amundi.)